Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Earnings beats mean a lot more when it happens to stocks the market gave up on.

Market Watch • Jun 3, 2026

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 13, 2026

Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting

Baxter International NYSE: BAX held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the election of nine directors, executive compensation, auditor ratification, an amended incentive plan and a change related to board size.

MarketBeat • May 10, 2026

Baxter International Still Has A Path To Upside

In recent years, stocks like Baxter International have underperformed: most low-growth, high-debt, struggling names have been bad investments at basically any price. Concerns are real, and early missteps under new CEO Andrew Hider haven't helped. But valuation is attractive not just on an absolute basis but also relative to the outlook, and Q1 results seemed helpful to the bull case.

Seeking Alpha • May 8, 2026

Madison Small Cap Fund Q1 2026 Portfolio Activity

ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.

Seeking Alpha • May 5, 2026

Baxter beats quarterly expectations on strong demand for medical devices

Baxter on Thursday beat Wall Street estimates for first-quarter profit and revenue, helped by robust sales ​in its medical products and therapies unit.

Reuters • Apr 30, 2026

Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript

Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 30, 2026

Baxter Reports First-Quarter 2026 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026. “Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution,” said Andrew Hider, president and CEO. “Although more work remains to achieve our full potential, Baxter continues to take the decisive steps nec.

Business Wire • Apr 30, 2026

Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates

Baxter International (BAX) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.55 per share a year ago.

Zacks Investment Research • Apr 30, 2026

Baxter (BAX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Apr 30, 2026